News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,760 Results
Type
Article (42850)
Company Profile (297)
Press Release (681612)
Multimedia
Podcasts (91)
Webinars (15)
Section
Business (210580)
Career Advice (2096)
Deals (36671)
Drug Delivery (107)
Drug Development (83160)
Employer Resources (175)
FDA (16647)
Job Trends (15440)
News (356414)
Policy (33998)
Tag
Academia (2600)
Accelerated approval (10)
Adcomms (23)
Allergies (101)
Alliances (51577)
ALS (112)
Alzheimer's disease (1464)
Antibody-drug conjugate (ADC) (161)
Approvals (16647)
Artificial intelligence (330)
Autoimmune disease (30)
Automation (19)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (128)
Biotechnology (188)
Bladder cancer (93)
Brain cancer (38)
Breast cancer (370)
Cancer (2919)
Cardiovascular disease (224)
Career advice (1758)
Career pathing (31)
CAR-T (188)
CDC (32)
Cell therapy (509)
Cervical cancer (22)
Clinical research (68424)
Collaboration (1046)
Company closure (3)
Compensation (695)
Complete response letters (29)
COVID-19 (2697)
CRISPR (62)
C-suite (337)
Cystic fibrosis (116)
Data (3024)
Decentralized trials (2)
Denatured (30)
Depression (64)
Diabetes (350)
Diagnostics (6509)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (143)
Drug pricing (135)
Drug shortages (31)
Duchenne muscular dystrophy (127)
Earnings (89166)
Editorial (42)
Employer branding (21)
Employer resources (151)
Events (116647)
Executive appointments (866)
FDA (18328)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (945)
Gene editing (136)
Generative AI (24)
Gene therapy (391)
GLP-1 (827)
Government (4630)
Grass and pollen (5)
Guidances (181)
Healthcare (19024)
HIV (40)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (158)
Immuno-oncology (10)
Indications (40)
Infectious disease (2870)
Inflammatory bowel disease (153)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (122)
Interviews (324)
IPO (16869)
IRA (51)
Job creations (4064)
Job search strategy (1494)
Kidney cancer (13)
Labor market (52)
Layoffs (518)
Leadership (19)
Legal (8401)
Liver cancer (80)
Longevity (12)
Lung cancer (405)
Lymphoma (211)
Machine learning (11)
Management (59)
Manufacturing (406)
MASH (92)
Medical device (13548)
Medtech (13553)
Mergers & acquisitions (20520)
Metabolic disorders (874)
Multiple sclerosis (97)
NASH (17)
Neurodegenerative disease (118)
Neuropsychiatric disorders (34)
Neuroscience (2164)
NextGen: Class of 2025 (6642)
Non-profit (4537)
Now hiring (47)
Obesity (444)
Opinion (242)
Ovarian cancer (102)
Pain (119)
Pancreatic cancer (121)
Parkinson's disease (188)
Partnered (22)
Patents (305)
Patient recruitment (169)
Peanut (53)
People (59685)
Pharmaceutical (91)
Pharmacy benefit managers (23)
Phase I (21224)
Phase II (30110)
Phase III (22546)
Pipeline (1655)
Policy (215)
Postmarket research (2654)
Preclinical (9058)
Press Release (68)
Prostate cancer (141)
Psychedelics (38)
Radiopharmaceuticals (259)
Rare diseases (480)
Real estate (6268)
Recruiting (68)
Regulatory (23512)
Reports (50)
Research institute (2375)
Resumes & cover letters (359)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (94)
Series A (161)
Series B (110)
Service/supplier (12)
Sickle cell disease (63)
Special edition (19)
Spinal muscular atrophy (151)
Sponsored (33)
Startups (3739)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (63)
The Weekly (59)
Vaccines (802)
Venture capital (54)
Weight loss (276)
Women's health (47)
Worklife (16)
Date
Today (91)
Last 7 days (355)
Last 30 days (1857)
Last 365 days (31691)
2025 (17086)
2024 (35771)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35772)
2017 (33138)
2016 (32662)
2015 (38616)
2014 (32516)
2013 (27631)
2012 (29729)
2011 (30487)
2010 (28498)
Location
Africa (783)
Alabama (61)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (41115)
Australia (6569)
California (7485)
Canada (2377)
China (695)
Colorado (323)
Connecticut (320)
Delaware (195)
Europe (87856)
Florida (1125)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (653)
India (28)
Indiana (370)
Iowa (16)
Japan (236)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1032)
Massachusetts (5605)
Michigan (248)
Minnesota (453)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2098)
New Mexico (29)
New York (2100)
North Carolina (1101)
North Dakota (8)
Northern California (3290)
Ohio (236)
Oklahoma (16)
Oregon (39)
Pennsylvania (1623)
Puerto Rico (17)
Rhode Island (36)
South America (1164)
South Carolina (35)
South Dakota (1)
Southern California (2799)
Tennessee (126)
Texas (1136)
United States (27855)
Utah (222)
Virginia (196)
Washington D.C. (72)
Washington State (641)
West Virginia (4)
Wisconsin (69)
724,760 Results for "lexicon pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
May 29, 2025
·
1 min read
Obesity
Novo’s Obesity Pipeline Keeps Evolving With up to $1B Lexicon Deal
Lexicon’s LX9851 targets ACSL5, a liver enzyme involved in fat metabolism that helps moderate fat accumulation and slow down gastric emptying.
March 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates
May 14, 2025
·
9 min read
Press Releases
Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
May 7, 2025
·
1 min read
Press Releases
Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
May 7, 2025
·
1 min read
Press Releases
Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA)
June 18, 2025
·
6 min read
Press Releases
Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
April 2, 2025
·
1 min read
Press Releases
Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
March 31, 2025
·
5 min read
Lone Star Bio
Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Jefferies Global Healthcare Conference.
May 29, 2024
·
2 min read
Lone Star Bio
Lexicon Pharmaceuticals to Host 2024 Investor Day
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024.
April 18, 2024
·
3 min read
1 of 72,476
Next
